| Trial ID: | L0801 |
| Source ID: | ChiCTR1800014364
|
| Associated Drug: |
Lingguizhugan decoction
|
| Title: |
Efficacy and safety of Lingguizhugan decoction for non-alcoholic fatty liver disease with yang deficiency of spleen: a three-arm, dose-optimization, randomized, placebo-controlled trial
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic fatty liver disease
|
| Interventions: |
1:Standard-dose Lingguizhugan decoction;2:Low-dose Lingguizhugan decoction;3:Placebo;
|
| Outcome Measures: |
Patients percentage who reaches one standard unit decrease of HOMA-IR;Inflammation markers;Liver function;Blood lipid metabolism;Blood glucose metabolism;Inflammatory cytokines;Liver-kidney echo ratio by ultrasound;Body weight;Body mass index;Quantitative rating of clinical symptoms and signs;MOS item short from health survey, SF-36;Self-rating Depressive Scale;Self-rating Anxiety Scale;
|
| Sponsor/Collaborators: |
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
|
| Gender: |
All
|
| Age: |
1880
|
| Phases: |
Post-market
|
| Enrollment: |
1:81;2:81;3:81;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
08/01/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
31 July 2018
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=24555
|
